OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis
Iago Pinal-Fernández, Ángela Quintana, José C. Milisenda, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 6, pp. 829-836
Open Access | Times Cited: 33
Iago Pinal-Fernández, Ángela Quintana, José C. Milisenda, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 6, pp. 829-836
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort study
Lotta Plomp, Hortense Chassepot, Dimitri Psimaras, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101192-101192
Closed Access | Times Cited: 4
Lotta Plomp, Hortense Chassepot, Dimitri Psimaras, et al.
The Lancet Regional Health - Europe (2025) Vol. 50, pp. 101192-101192
Closed Access | Times Cited: 4
Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes
Antonio Farina, Macarena Villagrán‐García, Alberto Vogrig, et al.
The Lancet Neurology (2023) Vol. 23, Iss. 1, pp. 81-94
Open Access | Times Cited: 40
Antonio Farina, Macarena Villagrán‐García, Alberto Vogrig, et al.
The Lancet Neurology (2023) Vol. 23, Iss. 1, pp. 81-94
Open Access | Times Cited: 40
Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study
Elianet Fonseca, José María Cabrera‐Maqueda, Raquel Ruiz‐García, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 12, pp. 1150-1159
Closed Access | Times Cited: 35
Elianet Fonseca, José María Cabrera‐Maqueda, Raquel Ruiz‐García, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 12, pp. 1150-1159
Closed Access | Times Cited: 35
Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases
Christopher Nelke, Simone Schmid, Felix Kleefeld, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 10
Christopher Nelke, Simone Schmid, Felix Kleefeld, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 10
Unraveling calcium dysregulation and autoimmunity in immune mediated rippling muscle disease
Samir R. Nath, Aneesha Dasgupta, Divyanshu Dubey, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Samir R. Nath, Aneesha Dasgupta, Divyanshu Dubey, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Emerging mechanisms and therapeutics in inflammatory muscle diseases
Sven Wischnewski, Hans-Werner Rausch, Chiseko Ikenaga, et al.
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Sven Wischnewski, Hans-Werner Rausch, Chiseko Ikenaga, et al.
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
B Cells in Breast Cancer Pathology
Mengyuan Li, Ángela Quintana, Elena Alberts, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1517-1517
Open Access | Times Cited: 17
Mengyuan Li, Ángela Quintana, Elena Alberts, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1517-1517
Open Access | Times Cited: 17
Peripheral nervous system immune-related adverse events due to checkpoint inhibition
M.J. O’Hare, Amanda C. Guidon
Nature Reviews Neurology (2024) Vol. 20, Iss. 9, pp. 509-525
Closed Access | Times Cited: 7
M.J. O’Hare, Amanda C. Guidon
Nature Reviews Neurology (2024) Vol. 20, Iss. 9, pp. 509-525
Closed Access | Times Cited: 7
Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis
Christopher Nelke, Christina B. Schroeter, Lukas Theissen, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 5, pp. 725-745
Open Access | Times Cited: 16
Christopher Nelke, Christina B. Schroeter, Lukas Theissen, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 5, pp. 725-745
Open Access | Times Cited: 16
Recent Updates on the Pathogenesis of Inflammatory Myopathies
Jon Musai, Andrew L. Mammen, Iago Pinal-Fernández
Current Rheumatology Reports (2024) Vol. 26, Iss. 12, pp. 421-430
Open Access | Times Cited: 5
Jon Musai, Andrew L. Mammen, Iago Pinal-Fernández
Current Rheumatology Reports (2024) Vol. 26, Iss. 12, pp. 421-430
Open Access | Times Cited: 5
Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions
Arun Rajan, Alisa K. Sivapiromrat, Meredith J. McAdams
Cancers (2024) Vol. 16, Iss. 7, pp. 1369-1369
Open Access | Times Cited: 4
Arun Rajan, Alisa K. Sivapiromrat, Meredith J. McAdams
Cancers (2024) Vol. 16, Iss. 7, pp. 1369-1369
Open Access | Times Cited: 4
Soluble biomarkers for immune checkpoint inhibitor-related encephalitis: A mini-review
Antonio Farina, Macarena Villagrán‐García, Bastien Joubert
Revue Neurologique (2024) Vol. 180, Iss. 9, pp. 982-988
Open Access | Times Cited: 4
Antonio Farina, Macarena Villagrán‐García, Bastien Joubert
Revue Neurologique (2024) Vol. 180, Iss. 9, pp. 982-988
Open Access | Times Cited: 4
Immune checkpoint inhibitor-associated inclusion body myositis
A. S. Sarmatova, Р. В. Орлова, Lyudmila N. Lebedeva, et al.
Clinical Case in Oncology (2025) Vol. 2, Iss. 3, pp. 79-85
Closed Access
A. S. Sarmatova, Р. В. Орлова, Lyudmila N. Lebedeva, et al.
Clinical Case in Oncology (2025) Vol. 2, Iss. 3, pp. 79-85
Closed Access
Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota
Alberto Vogrig, Marta Dentoni, Irene Florean, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Alberto Vogrig, Marta Dentoni, Irene Florean, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A Case of Seronegative Myopathy-Myocardial Injury Due to PD-1 Inhibitor and Literature Review
新源 苗
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 1544-1551
Closed Access
新源 苗
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 1544-1551
Closed Access
The pathogenesis of neurological immune-related adverse events following immune checkpoint inhibitor therapy
Magdalena Lerch, Sudarshini Ramanathan
Seminars in Immunology (2025) Vol. 78, pp. 101956-101956
Open Access
Magdalena Lerch, Sudarshini Ramanathan
Seminars in Immunology (2025) Vol. 78, pp. 101956-101956
Open Access
Restricting datasets to classifiable samples augments discovery of immune disease biomarkers
Gunther Glehr, Paloma Riquelme, Katharina Kronenberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Gunther Glehr, Paloma Riquelme, Katharina Kronenberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Immune Checkpoint Inhibitor-induced Myositis
Athira Jayan, Andrew L. Mammen, María E. Suärez-Almazor
Rheumatic Disease Clinics of North America (2024) Vol. 50, Iss. 2, pp. 281-290
Closed Access | Times Cited: 2
Athira Jayan, Andrew L. Mammen, María E. Suärez-Almazor
Rheumatic Disease Clinics of North America (2024) Vol. 50, Iss. 2, pp. 281-290
Closed Access | Times Cited: 2
Immune Checkpoint Inhibitor Myopathy
Grayson Beecher, Iago Pinal-Fernández, Andrew L. Mammen, et al.
Neurology (2024) Vol. 103, Iss. 11
Closed Access | Times Cited: 2
Grayson Beecher, Iago Pinal-Fernández, Andrew L. Mammen, et al.
Neurology (2024) Vol. 103, Iss. 11
Closed Access | Times Cited: 2
Highly multiplexed spatial analysis identifies tissue-resident memory T cells as drivers of ulcerative and immune checkpoint inhibitor colitis
Mick J M van Eijs, J. J. M. Ter Linde, Matthijs J.D. Baars, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107891-107891
Open Access | Times Cited: 5
Mick J M van Eijs, J. J. M. Ter Linde, Matthijs J.D. Baars, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107891-107891
Open Access | Times Cited: 5
A comprehensive review of dermatomyositis treatments - from rediscovered classics to promising horizons
Ecem Sevim, Dale Kobrin, María Casal-Domínguez, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 2, pp. 197-209
Closed Access | Times Cited: 4
Ecem Sevim, Dale Kobrin, María Casal-Domínguez, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 2, pp. 197-209
Closed Access | Times Cited: 4
Paraneoplastic myopathies
Andrew L. Mammen
Handbook of clinical neurology (2024), pp. 327-332
Closed Access | Times Cited: 1
Andrew L. Mammen
Handbook of clinical neurology (2024), pp. 327-332
Closed Access | Times Cited: 1
Differentiating idiopathic inflammatory myopathies by automated morphometric analysis of MHC‐1, MHC‐2 and ICAM‐1 in muscle tissue
Anna Nishimura, Christopher Nelke, Melanie Huber, et al.
Neuropathology and Applied Neurobiology (2024) Vol. 50, Iss. 4
Open Access | Times Cited: 1
Anna Nishimura, Christopher Nelke, Melanie Huber, et al.
Neuropathology and Applied Neurobiology (2024) Vol. 50, Iss. 4
Open Access | Times Cited: 1
Editorial: Inflammatory muscle diseases: an update
Jantima Tanboon, Merrilee Needham, Tahseen Mozaffar, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
Jantima Tanboon, Merrilee Needham, Tahseen Mozaffar, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
